down arrow

Medicamen Biotec

Part of MojoOne Strategy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE646B01010
  • NSEID: MEDICAMEQ
  • BSEID: 531146
INR
499.60
6.6 (1.34%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 16.83 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

495.90506.05

52 Week

377.00630.00
Valuation
Technical
Day's Volume

CASH

16.83 k (-76.27%) Volume

Shareholding (Dec 2024)

FII

0.05%

Held by 2 FIIs

DII

0.92%

Held by 0 DIIs

Promoter

42.99%

iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -6.62% of over the last 5 years

 
2

Stock is technically in a Mildly Bearish range

3

With ROE of 3.4, it has a Very Expensive valuation with a 2.9 Price to Book Value

4

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 635 Cr (Micro Cap)

stock-summary
P/E

75.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.20%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

3.40%

stock-summary
Price to Book

2.90

Revenue and Profits (1 Year):
Net Sales:
45 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.2%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-11.77%
0%
-11.77%
1 Year
14.78%
0.18%
14.96%
2 Years
-28.65%
0.29%
-28.36%
3 Years
-35.65%
0.47%
-35.18%
4 Years
-7.66%
0.68%
-6.98%
5 Years
78.36%
1.84%
80.2%

Latest dividend: 1 per share ex-dividend date: Sep-19-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.41%
EBIT Growth (5y)
-6.62%
EBIT to Interest (avg)
8.83
Debt to EBITDA (avg)
1.05
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.73
Tax Ratio
33.60%
Dividend Payout Ratio
11.63%
Pledged Shares
0
Institutional Holding
0.97%
ROCE (avg)
9.48%
ROE (avg)
7.47%
Valuation key factors
Factor
Value
P/E Ratio
75
Industry P/E
33
Price to Book Value
2.90
EV to EBIT
49.85
EV to EBITDA
30.20
EV to Capital Employed
2.79
EV to Sales
3.55
PEG Ratio
NA
Dividend Yield
0.20%
ROCE (Latest)
4.99%
ROE (Latest)
3.40%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.05%)

Promoter with highest holding

Shivalik Rasayan Limited (42.99%)

Highest Public shareholder

Pharmadanica A/s (10.54%)

Individual Investors Holdings

32.96%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -2.92% vs 30.69% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 44.58% vs -36.17% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.14",
          "val2": "46.50",
          "chgp": "-2.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.70",
          "val2": "4.89",
          "chgp": "37.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.76",
          "val2": "0.65",
          "chgp": "16.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.47",
          "val2": "2.40",
          "chgp": "44.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.84%",
          "val2": "10.52%",
          "chgp": "4.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 2.70% vs 28.31% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -59.23% vs -20.86% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "87.79",
          "val2": "85.48",
          "chgp": "2.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.76",
          "val2": "11.59",
          "chgp": "-24.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.75",
          "val2": "1.86",
          "chgp": "-5.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.32",
          "val2": "5.69",
          "chgp": "-59.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.98%",
          "val2": "13.56%",
          "chgp": "-3.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.72% vs 29.14% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -28.43% vs -26.12% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "132.93",
          "val2": "131.98",
          "chgp": "0.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.46",
          "val2": "16.48",
          "chgp": "-6.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.51",
          "val2": "2.51",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.79",
          "val2": "8.09",
          "chgp": "-28.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.63%",
          "val2": "12.49%",
          "chgp": "-0.86%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 27.29% vs 22.02% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -26.35% vs -0.40% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "179.31",
          "val2": "140.87",
          "chgp": "27.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.24",
          "val2": "23.88",
          "chgp": "-6.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.40",
          "val2": "2.92",
          "chgp": "50.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.93",
          "val2": "14.84",
          "chgp": "-26.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.40%",
          "val2": "16.95%",
          "chgp": "-4.55%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
45.14
46.50
-2.92%
Operating Profit (PBDIT) excl Other Income
6.70
4.89
37.01%
Interest
0.76
0.65
16.92%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.47
2.40
44.58%
Operating Profit Margin (Excl OI)
14.84%
10.52%
4.32%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -2.92% vs 30.69% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 44.58% vs -36.17% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
87.79
85.48
2.70%
Operating Profit (PBDIT) excl Other Income
8.76
11.59
-24.42%
Interest
1.75
1.86
-5.91%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.32
5.69
-59.23%
Operating Profit Margin (Excl OI)
9.98%
13.56%
-3.58%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 2.70% vs 28.31% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -59.23% vs -20.86% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
132.93
131.98
0.72%
Operating Profit (PBDIT) excl Other Income
15.46
16.48
-6.19%
Interest
2.51
2.51
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.79
8.09
-28.43%
Operating Profit Margin (Excl OI)
11.63%
12.49%
-0.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.72% vs 29.14% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -28.43% vs -26.12% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
179.31
140.87
27.29%
Operating Profit (PBDIT) excl Other Income
22.24
23.88
-6.87%
Interest
4.40
2.92
50.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.93
14.84
-26.35%
Operating Profit Margin (Excl OI)
12.40%
16.95%
-4.55%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 27.29% vs 22.02% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -26.35% vs -0.40% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Medicamen Biotech Ltd stock-summary
stock-summary
Medicamen Biotech Ltd
Micro Cap
Pharmaceuticals & Drugs
A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets. The Company has presence in 40+ countries. Its offerings include Finished Dosage Forms (FDF's) to African countries.
Company Coordinates stock-summary
Company Details
1506 Chiranjiv Tower 43, Nehru Place New Delhi New Delhi : 110019
stock-summary
Tel: 91-11-47589500
stock-summary
http://www.medicamen.com
stock-summary
cs@medicamen.com
Registrar Details
Link Intime India Pvt Ltd., Narang Tower 44, Community Centre, Naraina Industrial Area , Phase - 1, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."